Abeona Therapeutics (ABEO) Return on Assets (2011 - 2026)

Abeona Therapeutics' Return on Assets history runs 16 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Assets rose 1.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, up 1.0% from the prior year.
• Return on Assets was little changed at 0.0% in Q1 2026 per ABEO's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q2 2025 and bottomed at 0.03% in Q3 2022.
• The 5-year median for Return on Assets is 0.01% (2024), against an average of 0.01%.
• Across the five-year window, Return on Assets decreased 2 bps in 2022 and climbed 2 bps in 2023, its largest moves.
• Year by year, Return on Assets stood at 0.01% in 2022, then surged by 38 bps to 0.01% in 2023, then jumped by 54 bps to 0.0% in 2024, then jumped by 177 bps to 0.0% in 2025, then climbed by 0 bps to 0.0% in 2026.
• Per Business Quant, the three latest ABEO Return on Assets figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).